Table of Content


1    INTRODUCTION    34
1.1    STUDY OBJECTIVES    34
1.2    MARKET DEFINITION    34
1.2.1    INCLUSIONS AND EXCLUSIONS    34
1.3    MARKET SEGMENTATION    35
1.3.1    MARKETS COVERED    35
1.3.2    REGIONS COVERED    35
1.4    YEARS CONSIDERED    36
1.5    CURRENCY CONSIDERED    36
1.6    LIMITATIONS    36
1.7    STAKEHOLDERS    37
1.8    SUMMARY OF CHANGES    37
2    RESEARCH METHODOLOGY    38
2.1    RESEARCH APPROACH    38
FIGURE 1    BREAST IMAGING MARKET: RESEARCH DESIGN METHODOLOGY    38
2.1.1    SECONDARY RESEARCH    39
2.1.2    PRIMARY RESEARCH    40
2.1.2.1    Primary sources    40
2.1.2.2    Key industry insights    41
2.1.2.3    Breakdown of primaries    41
FIGURE 2    BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS    41
FIGURE 3    BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION    42
2.2    RECESSION IMPACT ANALYSIS    42
2.3    MARKET SIZE ESTIMATION    42
FIGURE 4    RESEARCH METHODOLOGY: HYPOTHESIS BUILDING    43
2.3.1    BOTTOM-UP APPROACH    44
2.3.1.1    Approach 1: Company revenue estimation approach    44
FIGURE 5    MARKET SIZE ESTIMATION FOR BREAST IMAGING MARKET: APPROACH 1 (COMPANY REVENUE ESTIMATION)    44
FIGURE 6    REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF HOLOGIC, INC.    45
2.3.1.2    Approach 2: Customer-based market estimation    45
FIGURE 7    BOTTOM-UP APPROACH FOR MARKET SIZE ESTIMATION: BREAST IMAGING MARKET    46
2.3.1.3    Growth forecast    46
2.3.1.4    CAGR projections    47
FIGURE 8    CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS    47
2.4    DATA TRIANGULATION APPROACH    48
FIGURE 9    DATA TRIANGULATION METHODOLOGY    48
2.5    MARKET SHARE ESTIMATION    48
2.6    ASSUMPTIONS    49
2.7    RISK ASSESSMENT    49
2.7.1    RISK ASSESSMENT: BREAST IMAGING MARKET    49
2.8    GROWTH RATE ASSUMPTIONS    50
3    EXECUTIVE SUMMARY    51
FIGURE 10    BREAST IMAGING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)    51
FIGURE 11    BREAST IMAGING MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)    52
FIGURE 12    BREAST IMAGING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)    52
FIGURE 13    BREAST IMAGING MARKET: GEOGRAPHIC SNAPSHOT    53
4    PREMIUM INSIGHTS    54
4.1    BREAST IMAGING MARKET OVERVIEW    54
FIGURE 14    RISING PREVALENCE OF BREAST CANCER TO DRIVE GROWTH    54
4.2    EUROPE: MAMMOGRAPHY MARKET, BY TYPE    55
FIGURE 15    3D BREAST TOMOSYNTHESIS SEGMENT TO REGISTER SIGNIFICANT GROWTH IN EUROPEAN MAMMOGRAPHY MARKET    55
4.3    NORTH AMERICA: BREAST IMAGING MARKET, BY PRODUCT    55
FIGURE 16    SOFTWARE AND SERVICES SEGMENT TO REGISTER SIGNIFICANT GROWTH IN NORTH AMERICAN MARKET DURING FORECAST PERIOD    55
4.4    ASIA PACIFIC: BREAST IMAGING MARKET, BY END USER    56
FIGURE 17    HOSPITALS AND CLINICS SEGMENT TO CONTINUE TO HOLD LARGEST SHARE IN ASIA PACIFIC MARKET    56
4.5    GEOGRAPHIC SNAPSHOT OF BREAST IMAGING MARKET    56
FIGURE 18    CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD    56
5    MARKET OVERVIEW    57
5.1    INTRODUCTION    57
5.2    MARKET DYNAMICS    57
FIGURE 19    BREAST IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    57
5.2.1    DRIVERS    58
5.2.1.1    Growing incidence of breast cancer    58
FIGURE 20    NUMBER OF NEW BREAST CANCER CASES IN 2020, BY KEY COUNTRY    58
5.2.1.2    Increasing public-private investments, funding, and grants    58
5.2.1.3    Growing awareness of early breast cancer detection    59
5.2.1.4    Technological advancements in breast imaging modalities    59
5.2.1.5    Growing geriatric population    60
5.2.2    RESTRAINTS    60
5.2.2.1    High cost of breast imaging systems    60
5.2.2.2    Stringent regulatory approval procedures    60
5.2.3    OPPORTUNITIES    61
5.2.3.1    Growth potential in emerging economies    61
5.2.3.2    Contract-based diagnostic solutions and mobile solutions    61
5.2.4    CHALLENGES    62
5.2.4.1    Side effects of radiation exposure    62
5.2.4.2    Errors in breast cancer screening and diagnosis    62
5.2.4.3    Increasing adoption of refurbished imaging systems    62
5.3    PORTER’S FIVE FORCES ANALYSIS    63
TABLE 1    BREAST IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS    63
5.3.1    THREAT OF NEW ENTRANTS    63
5.3.2    THREAT OF SUBSTITUTES    63
5.3.3    BARGAINING POWER OF SUPPLIERS    63
5.3.4    BARGAINING POWER OF BUYERS    63
5.3.5    INTENSITY OF COMPETITIVE RIVALRY    64
5.4    TRADE ANALYSIS FOR BREAST IMAGING EQUIPMENT    64
TABLE 2    IMPORT DATA FOR BREAST IMAGING/MAMMOGRAPHY, BY COUNTRY, 2018–2022 (USD THOUSAND)    64
TABLE 3    EXPORT DATA FOR BREAST IMAGING/MAMMOGRAPHY, BY COUNTRY, 2018–2022 (USD THOUSAND)    65
5.5    PATENT ANALYSIS    66
FIGURE 21    TOP 10 PATENT APPLICANTS FOR BREAST IMAGING (JANUARY 2012–DECEMBER 2022)    66
FIGURE 22    TOP 10 PATENT APPLICANTS FOR MAMMOGRAPHY (JANUARY 2012–DECEMBER 2022)    67
5.6    ECOSYSTEM COVERAGE: PARENT MARKET    68
5.7    VALUE CHAIN ANALYSIS    68
5.7.1    RESEARCH & DEVELOPMENT    68
5.7.2    MANUFACTURING & ASSEMBLY    68
5.7.3    DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES    68
FIGURE 23    BREAST IMAGING MARKET: VALUE CHAIN ANALYSIS    69
5.8    SUPPLY CHAIN ANALYSIS    69
5.8.1    PROMINENT COMPANIES    69
5.8.2    SMALL & MEDIUM-SIZED ENTERPRISES    69
5.8.3    END USERS    69
FIGURE 24    BREAST IMAGING MARKET: SUPPLY CHAIN ANALYSIS    70
5.9    PRICING TREND ANALYSIS    70
TABLE 4    AVERAGE SELLING PRICE FOR MAJOR BREAST IMAGING EQUIPMENT    70
5.10    TECHNOLOGY ANALYSIS    71
5.11    REGULATORY LANDSCAPE    71
5.11.1    NORTH AMERICA    71
5.11.1.1    US    71
TABLE 5    US FDA: MEDICAL DEVICE CLASSIFICATION    72
TABLE 6    US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS    72
5.11.1.2    Canada    72
TABLE 7    CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS    73
5.11.2    EUROPE    73
5.11.3    ASIA PACIFIC    74
5.11.3.1    Japan    74
TABLE 8    JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA    74
5.11.3.2    China    74
TABLE 9    CHINA: CLASSIFICATION OF MEDICAL DEVICES    75
5.11.3.3    India    76
5.12    REIMBURSEMENT SCENARIO    77
TABLE 10    MEDICAL REIMBURSEMENT CODES FOR MAMMOGRAPHY IMAGING PROCEDURES IN US (AS OF 2022)    77
5.13    CASE STUDIES    78
5.13.1    TECHNOLOGICAL CHALLENGES    78
TABLE 11    CASE STUDY 1: BETTER VISUALIZATION OF BREAST IMAGES IN WOMEN WITH DENSE BREAST TISSUE    78
5.14    KEY CONFERENCES AND EVENTS (2023–2024)    78
TABLE 12    BREAST IMAGING MARKET: LIST OF MAJOR CONFERENCES AND EVENTS    78
6    BREAST IMAGING MARKET, BY TECHNOLOGY    80
6.1    INTRODUCTION    81
TABLE 13    BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)    81
6.2    IONIZING BREAST IMAGING TECHNOLOGIES    81
TABLE 14    IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    82
6.2.1    MAMMOGRAPHY    82
TABLE 15    MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)    82
TABLE 16    MAMMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)    83
TABLE 17    NORTH AMERICA: MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    83
TABLE 18    EUROPE: MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    84
TABLE 19    ASIA PACIFIC: MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    84
TABLE 20    LATIN AMERICA: MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    85
TABLE 21    MAMMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION)    85
TABLE 22    MAMMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    85
6.2.1.1    Full-field digital mammography (FFDM)    86
6.2.1.1.1    Use of lower radiation doses to drive growth    86
TABLE 23    FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)    86
TABLE 24    NORTH AMERICA: FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    87
TABLE 25    EUROPE: FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    87
TABLE 26    ASIA PACIFIC: FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    88
TABLE 27    LATIN AMERICA: FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    88
TABLE 28    FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION)    89
TABLE 29    FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    89
6.2.1.2    Analog mammography    89
6.2.1.2.1    High spatial resolution and low installation cost to boost adoption    89
TABLE 30    ANALOG MAMMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)    90
TABLE 31    NORTH AMERICA: ANALOG MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    91
TABLE 32    EUROPE: ANALOG MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    91
TABLE 33    ASIA PACIFIC: ANALOG MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    92
TABLE 34    LATIN AMERICA: ANALOG MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    92
TABLE 35    ANALOG MAMMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION)    93
TABLE 36    ANALOG MAMMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    93
6.2.1.3    3D breast tomosynthesis    93
6.2.1.3.1    3D breast tomosynthesis to witness highest growth in mammography market    93
TABLE 37    3D BREAST TOMOSYNTHESIS MARKET, BY REGION, 2021–2028 (USD MILLION)    94
TABLE 38    NORTH AMERICA: 3D BREAST TOMOSYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    94
TABLE 39    EUROPE: 3D BREAST TOMOSYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    95
TABLE 40    ASIA PACIFIC: 3D BREAST TOMOSYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    95
TABLE 41    LATIN AMERICA: 3D BREAST TOMOSYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    96
TABLE 42    3D BREAST TOMOSYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)    96
TABLE 43    3D BREAST TOMOSYNTHESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    97
6.2.1.4    Contrast-enhanced mammography (CEM)    97
6.2.1.4.1    Affordability over breast MRI and improved diagnostic accuracy to drive growth    97
TABLE 44    CONTRAST-ENHANCED MAMMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)    98
TABLE 45    NORTH AMERICA: CONTRAST-ENHANCED MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    98
TABLE 46    EUROPE: CONTRAST-ENHANCED MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    99
TABLE 47    ASIA PACIFIC: CONTRAST-ENHANCED MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    99
TABLE 48    LATIN AMERICA: CONTRAST-ENHANCED MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    100
TABLE 49    CONTRAST-ENHANCED MAMMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION)    100
TABLE 50    CONTRAST-ENHANCED MAMMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    101
6.2.2    POSITRON EMISSION MAMMOGRAPHY (PEM)    101
6.2.2.1    Higher sensitivity and accuracy to drive adoption    101
TABLE 51    POSITRON EMISSION MAMMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)    102
TABLE 52    NORTH AMERICA: POSITRON EMISSION MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    102
TABLE 53    EUROPE: POSITRON EMISSION MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    103
TABLE 54    ASIA PACIFIC: POSITRON EMISSION MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    103
TABLE 55    LATIN AMERICA: POSITRON EMISSION MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    104
TABLE 56    POSITRON EMISSION MAMMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION)    104
TABLE 57    POSITRON EMISSION MAMMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    105
6.2.3    POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT)    105
6.2.3.1    Combined scans from PET and CT offer more accurate results    105
TABLE 58    POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)    106
TABLE 59    NORTH AMERICA: POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    106
TABLE 60    EUROPE: POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    107
TABLE 61    ASIA PACIFIC: POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    107
TABLE 62    LATIN AMERICA: POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    108
TABLE 63    POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION)    108
TABLE 64    POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    109
6.2.4    MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING (MBI/BSGI)    109
6.2.4.1    High sensitivity to drive growth    109
TABLE 65    MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY REGION, 2021–2028 (USD MILLION)    110
TABLE 66    NORTH AMERICA: MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    110
TABLE 67    EUROPE: MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    111
TABLE 68    ASIA PACIFIC: MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    111
TABLE 69    LATIN AMERICA: MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    112
TABLE 70    MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)    112
TABLE 71    MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    113
6.2.5    CONE-BEAM COMPUTED TOMOGRAPHY (CBCT)    113
6.2.5.1    CBCT segment to witness stable growth during forecast period    113
TABLE 72    CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)    114
TABLE 73    NORTH AMERICA: CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    114
TABLE 74    EUROPE: CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    115
TABLE 75    ASIA PACIFIC: CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    115
TABLE 76    LATIN AMERICA: CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    116
TABLE 77    CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION)    116
TABLE 78    CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    117
6.3    NON-IONIZING BREAST IMAGING TECHNOLOGIES    117
TABLE 79    NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    118
6.3.1    BREAST ULTRASOUND    118
6.3.1.1    Rising awareness and easy availability of ultrasound devices for breast imaging to drive growth    118
TABLE 80    BREAST ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION)    119
TABLE 81    NORTH AMERICA: BREAST ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    119
TABLE 82    EUROPE: BREAST ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    120
TABLE 83    ASIA PACIFIC: BREAST ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    120
TABLE 84    LATIN AMERICA: BREAST ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    121
TABLE 85    BREAST ULTRASOUND MARKET, BY END USER, 2021–2028 (USD MILLION)    121
TABLE 86    BREAST ULTRASOUND MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    122
6.3.2    BREAST MRI    122
6.3.2.1    Technological advancements in breast MRI to drive growth    122
TABLE 87    BREAST MRI MARKET, BY REGION, 2021–2028 (USD MILLION)    123
TABLE 88    NORTH AMERICA: BREAST MRI MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    123
TABLE 89    EUROPE: BREAST MRI MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    124
TABLE 90    ASIA PACIFIC: BREAST MRI MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    124
TABLE 91    LATIN AMERICA: BREAST MRI MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    125
TABLE 92    BREAST MRI MARKET, BY END USER, 2021–2028 (USD MILLION)    125
TABLE 93    BREAST MRI MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    125
6.3.3    AUTOMATED WHOLE-BREAST ULTRASOUND (AWBU)    126
6.3.3.1    AWBU helps spot small cancers in mammograms of dense breasts    126
TABLE 94    AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION)    126
TABLE 95    NORTH AMERICA: AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    127
TABLE 96    EUROPE: AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    127
TABLE 97    ASIA PACIFIC: AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    128
TABLE 98    LATIN AMERICA: AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    128
TABLE 99    AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY END USER, 2021–2028 (USD MILLION)    129
TABLE 100    AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    129
6.3.4    BREAST THERMOGRAPHY    130
6.3.4.1    Rising popularity due to reduced exposure to harmful radiation to boost adoption    130
TABLE 101    BREAST THERMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)    130
TABLE 102    NORTH AMERICA: BREAST THERMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    131
TABLE 103    EUROPE: BREAST THERMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    131
TABLE 104    ASIA PACIFIC: BREAST THERMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    132
TABLE 105    LATIN AMERICA: BREAST THERMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    132
TABLE 106    BREAST THERMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION)    133
TABLE 107    BREAST THERMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    133
6.3.5    ELECTRIC IMPEDANCE TOMOGRAPHY    133
6.3.5.1    Affordability and quick results to drive growth    133
TABLE 108    ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)    134
TABLE 109    NORTH AMERICA: ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    134
TABLE 110    EUROPE: ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    135
TABLE 111    ASIA PACIFIC: ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    135
TABLE 112    LATIN AMERICA: ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    136
TABLE 113    ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION)    136
TABLE 114    ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    137
6.3.6    OPTICAL IMAGING    137
6.3.6.1    High sensitivity, easy accessibility, and lower cost to support growth    137
TABLE 115    OPTICAL IMAGING MARKET, BY REGION, 2021–2028 (USD MILLION)    137
TABLE 116    NORTH AMERICA: OPTICAL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    138
TABLE 117    EUROPE: OPTICAL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    138
TABLE 118    ASIA PACIFIC: OPTICAL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    139
TABLE 119    LATIN AMERICA: OPTICAL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    139
TABLE 120    OPTICAL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)    140
TABLE 121    OPTICAL IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    140
7    BREAST IMAGING MARKET, BY PRODUCT    141
7.1    INTRODUCTION    142
TABLE 122    BREAST IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    142
7.2    BREAST IMAGING SYSTEMS    142
7.2.1    SIGNIFICANT TECHNOLOGICAL DEVELOPMENTS TO FUEL GROWTH    142
TABLE 123    BREAST IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)    143
7.3    SOFTWARE AND SERVICES    143
7.3.1    INTRODUCTION OF NOVEL IMAGING SOFTWARE TO SUPPORT GROWTH    143
TABLE 124    BREAST IMAGING SOFTWARE AND SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)    144
7.4    ACCESSORIES    144
7.4.1    INCREASING ADOPTION OF BREAST IMAGING EQUIPMENT TO BOOST GROWTH    144
TABLE 125    BREAST IMAGING ACCESSORIES MARKET, BY REGION, 2021–2028 (USD MILLION)    145
8    BREAST IMAGING MARKET, BY END USER    146
8.1    INTRODUCTION    147
TABLE 126    BREAST IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)    147
8.2    HOSPITALS AND CLINICS    147
8.2.1    RISING DEMAND FOR QUICK AND ACCURATE DIAGNOSIS TO BOOST GROWTH    147
TABLE 127    BREAST IMAGING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2021–2028 (USD MILLION)    148
8.3    DIAGNOSTIC IMAGING CENTERS    148
8.3.1    RISING NUMBER OF PRIVATE IMAGING CENTERS CONTRIBUTING TO GROWTH    148
TABLE 128    BREAST IMAGING MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2021–2028 (USD MILLION)    149
8.4    BREAST CARE CENTERS    149
8.4.1    INCREASING INCLINATION TOWARD BREAST CARE CENTERS OBSERVED IN DEVELOPED COUNTRIES    149
TABLE 129    BREAST IMAGING MARKET FOR BREAST CARE CENTERS, BY REGION, 2021–2028 (USD MILLION)    150
8.5    OTHER END USERS    150
TABLE 130    BREAST IMAGING MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)    151
9    BREAST IMAGING MARKET, BY REGION    152
9.1    INTRODUCTION    153
TABLE 131    BREAST IMAGING MARKET, BY REGION, 2021–2028 (USD MILLION)    153
9.2    NORTH AMERICA    153
FIGURE 25    NORTH AMERICA: BREAST IMAGING MARKET SNAPSHOT    154
TABLE 132    NORTH AMERICA: BREAST IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    154
TABLE 133    NORTH AMERICA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)    155
TABLE 134    NORTH AMERICA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    155
TABLE 135    NORTH AMERICA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)    156
TABLE 136    NORTH AMERICA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    156
TABLE 137    NORTH AMERICA: BREAST IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    157
TABLE 138    NORTH AMERICA: BREAST IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)    157
9.2.1    US    157
9.2.1.1    US to dominate North American breast imaging market during forecast period    157
TABLE 139    US: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)    158
TABLE 140    US: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    159
TABLE 141    US: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)    159
TABLE 142    US: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    160
9.2.2    CANADA    160
9.2.2.1    Increasing incidence of breast cancer and favorable government guidelines to support growth    160
TABLE 143    CANADA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)    161
TABLE 144    CANADA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    161
TABLE 145    CANADA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)    162
TABLE 146    CANADA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    162
9.3    EUROPE    163
TABLE 147    EUROPE: BREAST IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    163
TABLE 148    EUROPE: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)    163
TABLE 149    EUROPE: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    164
TABLE 150    EUROPE: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)    164
TABLE 151    EUROPE: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    165
TABLE 152    EUROPE: BREAST IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    165
TABLE 153    EUROPE: BREAST IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)    166
9.3.1    GERMANY    166
9.3.1.1    Rising utilization of ionizing and non-ionizing imaging technologies to boost growth    166
TABLE 154    GERMANY: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)    167
TABLE 155    GERMANY: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    167
TABLE 156    GERMANY: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)    168
TABLE 157    GERMANY: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    168
9.3.2    FRANCE    169
9.3.2.1    Growing government initiatives and modernization of healthcare infrastructure fueling growth    169
TABLE 158    FRANCE: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)    169
TABLE 159    FRANCE: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    170
TABLE 160    FRANCE: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)    170
TABLE 161    FRANCE: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    171
9.3.3    UK    171
9.3.3.1    Growing funding opportunities for supporting cancer research to drive growth    171
TABLE 162    UK: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)    172
TABLE 163    UK: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    172
TABLE 164    UK: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)    173
TABLE 165    UK: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    173
9.3.4    ITALY    174
9.3.4.1    Evolving regulatory scenario for breast imaging and rising incidence of cancer to drive growth    174
TABLE 166    ITALY: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)    174
TABLE 167    ITALY: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    175
TABLE 168    ITALY: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)    175
TABLE 169    ITALY: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    176
9.3.5    SPAIN    176
9.3.5.1    Growing geriatric population to drive growth    176
TABLE 170    SPAIN: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)    177
TABLE 171    SPAIN: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    177
TABLE 172    SPAIN: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)    178
TABLE 173    SPAIN: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    178
9.3.6    REST OF EUROPE    179
TABLE 174    REST OF EUROPE: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)    179
TABLE 175    REST OF EUROPE: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    180
TABLE 176    REST OF EUROPE: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)    180
TABLE 177    REST OF EUROPE: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    181
9.4    ASIA PACIFIC    181
FIGURE 26    ASIA PACIFIC: BREAST IMAGING MARKET SNAPSHOT    182
TABLE 178    ASIA PACIFIC: BREAST IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    182
TABLE 179    ASIA PACIFIC: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)    183
TABLE 180    ASIA PACIFIC: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    183
TABLE 181    ASIA PACIFIC: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)    184
TABLE 182    ASIA PACIFIC: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    184
TABLE 183    ASIA PACIFIC: BREAST IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    185
TABLE 184    ASIA PACIFIC: BREAST IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)    185

9.4.1    JAPAN    185
9.4.1.1    Rising breast cancer cases and presence of universal healthcare reimbursement scenario to fuel growth    185
TABLE 185    JAPAN: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)    186
TABLE 186    JAPAN: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    187
TABLE 187    JAPAN: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)    187
TABLE 188    JAPAN: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    188
9.4.2    CHINA    188
9.4.2.1    Government initiatives for healthcare development to fuel growth    188
TABLE 189    CHINA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)    189
TABLE 190    CHINA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    189
TABLE 191    CHINA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)    190
TABLE 192    CHINA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    190
9.4.3    INDIA    191
9.4.3.1    Rising government initiatives focused on improving female health to drive growth    191
TABLE 193    INDIA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)    191
TABLE 194    INDIA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    192
TABLE 195    INDIA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)    192
TABLE 196    INDIA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    193
9.4.4    AUSTRALIA    193
9.4.4.1    Rising research funding and awareness campaigns to support growth    193
TABLE 197    AUSTRALIA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)    194
TABLE 198    AUSTRALIA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    194
TABLE 199    AUSTRALIA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)    195
TABLE 200    AUSTRALIA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    195
9.4.5    SOUTH KOREA    196
9.4.5.1    Rising government initiatives to drive growth    196
TABLE 201    SOUTH KOREA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)    196
TABLE 202    SOUTH KOREA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    196
TABLE 203    SOUTH KOREA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)    197
TABLE 204    SOUTH KOREA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    197
9.4.6    REST OF ASIA PACIFIC    198
TABLE 205    REST OF ASIA PACIFIC: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)    198
TABLE 206    REST OF ASIA PACIFIC: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    198
TABLE 207    REST OF ASIA PACIFIC: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)    199
TABLE 208    REST OF ASIA PACIFIC: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    199
9.5    LATIN AMERICA    200
TABLE 209    LATIN AMERICA: BREAST IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    200
TABLE 210    LATIN AMERICA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)    201
TABLE 211    LATIN AMERICA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    201
TABLE 212    LATIN AMERICA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)    202
TABLE 213    LATIN AMERICA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    202
TABLE 214    LATIN AMERICA: BREAST IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    203
TABLE 215    LATIN AMERICA: BREAST IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)    203
9.5.1    BRAZIL    203
9.5.1.1    Rising modernization of healthcare facilities to drive growth    203
TABLE 216    BRAZIL: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)    204
TABLE 217    BRAZIL: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    204
TABLE 218    BRAZIL: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)    205
TABLE 219    BRAZIL: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    205
9.5.2    MEXICO    206
9.5.2.1    Availability of advanced care and increasing awareness programs to fuel growth    206
TABLE 220    MEXICO: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)    206
TABLE 221    MEXICO: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    207
TABLE 222    MEXICO: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)    207
TABLE 223    MEXICO: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    208
9.5.3    REST OF LATIN AMERICA    208
TABLE 224    REST OF LATIN AMERICA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)    209
TABLE 225    REST OF LATIN AMERICA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    209
TABLE 226    REST OF LATIN AMERICA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)    210
TABLE 227    REST OF LATIN AMERICA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    210
9.6    MIDDLE EAST & AFRICA    211
9.6.1    IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE GROWTH    211
TABLE 228    MIDDLE EAST & AFRICA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)    211
TABLE 229    MIDDLE EAST & AFRICA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    212
TABLE 230    MIDDLE EAST & AFRICA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION)    212
TABLE 231    MIDDLE EAST & AFRICA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    213
TABLE 232    MIDDLE EAST & AFRICA: BREAST IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    213
TABLE 233    MIDDLE EAST & AFRICA: BREAST IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)    214
10    COMPETITIVE LANDSCAPE    215
10.1    OVERVIEW    215
10.2    RIGHT TO WIN    215
10.3    STRATEGIES OF KEY PLAYERS    216
FIGURE 27    KEY DEVELOPMENTS IN BREAST IMAGING MARKET    216
10.4    REVENUE SHARE ANALYSIS    216
FIGURE 28    REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS IN BREAST IMAGING MARKET (2020–2022)    216
10.5    MARKET SHARE ANALYSIS    217
FIGURE 29    GE HEALTHCARE HELD LEADING POSITION IN BREAST IMAGING MARKET IN 2022    217
TABLE 234    BREAST IMAGING MARKET: DEGREE OF COMPETITION    217
10.6    COMPANY EVALUATION MATRIX (2022)    218
10.6.1    VENDOR INCLUSION CRITERIA    218
10.6.2    STARS    219
10.6.3    PERVASIVE PLAYERS    219
10.6.4    EMERGING LEADERS    219
10.6.5    PARTICIPANTS    219
FIGURE 30    BREAST IMAGING MARKET: COMPANY EVALUATION MATRIX, 2022    220
10.7    COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022)    221
10.7.1    PROGRESSIVE COMPANIES    221
10.7.2    STARTING BLOCKS    221
10.7.3    RESPONSIVE COMPANIES    221
10.7.4    DYNAMIC COMPANIES    221
FIGURE 31    BREAST IMAGING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022    222
10.8    COMPETITIVE BENCHMARKING    223
TABLE 235    PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN BREAST IMAGING MARKET    223
10.9    COMPETITIVE SCENARIO AND TRENDS    223
10.9.1    PRODUCT LAUNCHES    223
TABLE 236    BREAST IMAGING MARKET: PRODUCT LAUNCHES, JANUARY 2020–MAY 2023    223
10.9.2    DEALS    225
TABLE 237    BREAST IMAGING MARKET: DEALS, JANUARY 2020–MAY 2023    225
10.9.3    OTHER DEVELOPMENTS    227
TABLE 238    BREAST IMAGING MARKET: OTHER DEVELOPMENTS, JANUARY 2020–MAY 2023    227"    "11    COMPANY PROFILES    228
11.1    KEY PLAYERS    228
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1    GE HEALTHCARE (PART OF GENERAL ELECTRIC COMPANY)    228
TABLE 239    GE HEALTHCARE: COMPANY OVERVIEW    228
FIGURE 32    GE HEALTHCARE: COMPANY SNAPSHOT (2022)    229
11.1.2    HOLOGIC, INC.    232
TABLE 240    HOLOGIC, INC.: COMPANY OVERVIEW    232
FIGURE 33    HOLOGIC, INC.: COMPANY SNAPSHOT (2022)    233
11.1.3    SIEMENS HEALTHCARE GMBH    237
TABLE 241    SIEMENS HEALTHCARE GMBH: COMPANY OVERVIEW    237
FIGURE 34    SIEMENS HEALTHCARE GMBH: COMPANY SNAPSHOT (2022)    238
11.1.4    KONINKLIJKE PHILIPS N.V.    242
TABLE 242    KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW    242
FIGURE 35    KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)    243
11.1.5    FUJIFILM HOLDINGS CORPORATION    245
TABLE 243    FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW    245
FIGURE 36    FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022)    246
11.1.6    CANON INC.    248
TABLE 244    CANON INC.: COMPANY OVERVIEW    248
FIGURE 37    CANON INC.: COMPANY SNAPSHOT (2022)    249
11.1.7    AURORA HEALTHCARE US CORP.    252
11.1.8    ALLENGERS    254
11.1.9    DILON TECHNOLOGIES, INC.    255
11.1.10    PLANMED OY    256
11.1.11    DELPHINUS MEDICAL TECHNOLOGIES, INC.    258
11.1.12    MICRIMA LIMITED    259
11.1.13    CMR NAVISCAN    260
11.1.14    METALTRONICA S.P.A.    261
11.1.15    CAPERAY    262
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11.2    OTHER PLAYERS    263
11.2.1    KUB TECHNOLOGIES    263
11.2.2    SONOCINÉ    264
11.2.3    NP JSC AMICO    264
11.2.4    QT IMAGING, INC.    265
11.2.5    IMAGING DIAGNOSTIC SYSTEMS, INC.    265
11.2.6    SENO MEDICAL    266
11.2.7    ONCOVISION    266
11.2.8    VILLA SISTEMI MEDICALI SPA    267
11.2.9    TRIVITRON HEALTHCARE    267
11.2.10    ISONO HEALTH, INC.    268
12    APPENDIX    269
12.1    DISCUSSION GUIDE    269
12.2    KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL    273
12.3    CUSTOMIZATION OPTIONS    275
12.4    RELATED REPORTS    275
12.5    AUTHOR DETAILS    276